Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Glaukos Corp (NY: GKOS)
69.45 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 4:02 PM EDT, Apr 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) 69.44 (16)
Ask (Size) 69.45 (13)
Prev. Close 69.45
Today's Range 69.45 - 69.45
52wk Range 29.09 - 83.14
Shares Outstanding 34,906,021
Dividend Yield N/A
Performance
YTD
+29.21%
+29.21%
1 Month
-7.58%
-7.58%
3 Month
+11.32%
+11.32%
6 Month
+11.44%
+11.44%
1 Year
+133.84%
+133.84%
Top News
More News
New Research: Key Drivers of Growth for Fresh Del Monte Produce, Baker Hughes, a GE company, HollyFrontier, Glaukos, HCI Group, and Revance Therapeutics — Factors of Influence, Major Initiatives and S
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fresh Del Monte Produce,... Read More
from GlobeNewswire News Releases
Glaukos Corporation to Release First Quarter 2019 Financial Results after Market Close on May 8
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical... Read More
from Business Wire News Releases
More News
Read More
Prospective, Randomized Trial Highlights 5-Year Performance of 2 Standalone Glaukos iStents® vs. Topical Prostaglandin in Newly Diagnosed Glaucoma Patients
from Business Wire News Releases
Pivotal Trial Results for Glaukos’ iStent inject® Published in Leading Ophthalmic Journal
from Business Wire News Releases
Glaukos Technologies Featured in Numerous Presentations at 2019 American Glaucoma Society Meeting
from Business Wire News Releases
International Glaucoma Study Confirms Long-term Efficacy and Safety Profile of Glaukos iStent® Implantation in Combination with Cataract Surgery
from Business Wire News Releases
Glaukos Corporation Announces Fourth Quarter and Full Year 2018 Financial Results
from Business Wire News Releases
Glaukos Corporation to Release Fourth Quarter and Full Year 2018 Financial Results after Market Close on February 27
from Business Wire News Releases
Uptrend Call Working As Glaukos Corp Stock Rises 24.3% (GKOS)
from Comtex SmarTrend® News Briefs
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
from Business Wire News Releases
Glaukos Corp (GKOS) Q4 2018 Earnings Conference Call Transcript
category fbn/markets , 3774b14c/00ee/511b/ab06/2439ad57356b , Motley Fool , and 3 more.
from FOX Business
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.